Enanta Pharmaceuticals announced the appointment of Matthew Kowalsky as chief legal officer.

In this role, he will lead all legal and compliance activities for Enanta, as well as provide strategic guidance and corporate governance oversight.

Previously, Kowalsky held legal and operational roles of increasing responsibility at Sigilon Therapeutics until its acquisition by Eli Lilly in 2023. Most recently, he served as the chief of staff and chief legal and administrative officer of Sigilon, which he joined in 2019 as general counsel and corporate secretary.

Prior to this, he was vice president of legal and corporate secretary at Proteon Therapeutics.